<DOC>
	<DOC>NCT00749775</DOC>
	<brief_summary>To collect the efficacy and safety information of Eplerenone on patients with hypertension related to their appropriate use in daily practice.</brief_summary>
	<brief_title>Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<criteria>Male or Female patients who are prescribed Selara tablet for Hypertension. Subjects who have been prescribed Selara tablet.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Eplerenone</keyword>
	<keyword>Selara</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Good post-marketing study Practice</keyword>
	<keyword>Drug use Investigation</keyword>
	<keyword>Regulatory Post Marketing Commitment Plan</keyword>
	<keyword>ESSENCE</keyword>
</DOC>